Clinical Trial Update: Evaluation of the Efficacy and Safety of MV130 in Chronic Obstructive Pulmonary Disease (COPD) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports the results of evaluating MV130 for chronic obstructive pulmonary disease in Phase 2/3. The study completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• MV130

Snippet

Sponsor: Inmunotek S.L. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-10-02